Researchers are developing AI programmes to make doping detection more effective, faster, and cheaper. How do these systems ...

David Brailsford will again pull the strings for the Jim Ratcliffe-owned Team Ineos Grenadiers at this year’s Tour de France, which starts in Lille today.

FDA approval of EKTERLY makes KalVista Pharmaceuticals, Inc. the first to offer an oral on-demand HAE therapy. Click here to find out why KALV is a Strong Buy.

Rhythm Pharmaceuticals' potential first-in-class HO drug, strong pipeline, and limited competition offer blockbuster potential. Click to read why RYTM is a Buy.

The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should see earnings gains through the end of the decade.

Novo Nordisk has launched direct-to-consumer sales of its obesity drug Wegovy for uninsured or under-insured people at $499 per month.

Verona Pharma has blockbuster hopes for its recently approved drug for chronic obstructive pulmonary disorder (COPD), and preliminary sales figures for the drug suggest it is heading in the right ...

"Far from being healthy environments for the body and the mind, the gyms were allegedly turned into drug supermarkets of the many defendants who openly and illegally sold performance drugs ...

A former Allentown Police officer, accused of stealing drug money and having sex with a prostitute while on duty, had some of those charges withdrawn Monday.